United States Patent and Trademark Office Issues Notification For Patent Covering the Kelyniam Global's Integrated Fixation Tabs, Currently Marketed as Ifs Tabs or Kwiktabs
December 01, 2021 at 09:06 pm EST
Share
Kelyniam Global, announced that the United States Patent and Trademark Office has issued the company an Issue Notification for a patent covering the company's Integrated Fixation Tabs, currently marketed as IFS Tabs or KwikTabs. The US patent covers the integration of fixation appendages into a cranial implant and their design. The patent was filed in 2014 and will run through 2037. The company intends to vigorously defend the patent and will ensure the Company's historical and future interests in this innovative technology will be protected. Integrated fixation can eliminate the need for expensive plates and screws, saving patients thousands of dollars per procedure. Surgeons work with a Kelyniam Design Engineer to place the fixation tabs exactly where they are needed, which also facilitates surgical planning. Not having to place unwieldly plates and screws to secure an implant can reduce the amount of surgical time, an important benefit in cranial surgery. Fewer plates and screws can also result in a more cosmetically elegant fit for the patient.
Kelyniam Global, Inc. is a custom design-to-build medical device manufacturing company. The Company specializes in the delivery of cranial implant technologies to neurologically dependent patients. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patientâs computed tomography (CT) data, the Companyâs 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its K-Plans include ke24, ke72 and kp5day. The Companyâs emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours.
United States Patent and Trademark Office Issues Notification For Patent Covering the Kelyniam Global's Integrated Fixation Tabs, Currently Marketed as Ifs Tabs or Kwiktabs